Skip to content
Screener

OrthoPediatrics KIDS Operating Cash Flow

Operating Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$8.62B+122%
Stryker logo
StrykerSYK
$1.26B+13.5%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$6.22M-153%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$447.8M+18.4%
Medtronic logo
MedtronicMDT
$2.57B+1.8%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
$7.24M+72.5%

Other financials

Income statement

See full
Revenue$70.5M+15.4%
Gross profit$52.4M+19.0%
Operating income-$4.1M+61.8%
Net income-$7.2M-0.7%
EPS (diluted)-$0.300.0%

Balance sheet

See full
Cash & equivalents$19.1M-59.1%
Total debt$4.6M+234%
Total equity$343.6M-3.3%
Total assets$511.4M+1.5%

Cash flow

See full
CapEx$4.0M+17.4%
Free cash flow-$3.1M+77.6%

Valuation

See full
Market cap$594.52M+26.1%
Enterprise value$580.02M+36.0%
P/S2.4×+0.2×

Profitability

See full
Gross margin73.7%+2.1pp
Operating margin-11.9%-3.2pp
Net margin-15.7%-2.3pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.4%-0.1pp
Debt / equity0.0×
Current ratio4.8×-1.9×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: OrthoPediatrics’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 3:45 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001425450-26-000036
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Accounts payable - trade7045,207
Accrued expenses and other liabilities(3,571)(2,528)
Other1,283(1,558)
Net cash used in operating activities(3,287)(4,156)
INVESTING ACTIVITIES
Other acquisitions, including clinics, net of cash acquired(6,777)(220)
Sale of short-term marketable securities5,000
Investment in private companies and purchases of licenses(250)(1,540)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is OrthoPediatrics's operating cash flow?
OrthoPediatrics (KIDS) reported operating cash flow of -$3.29M in Q1 2026.
How has OrthoPediatrics's operating cash flow changed year-over-year?
OrthoPediatrics's operating cash flow increased by 20.9% year-over-year, from -$4.16M to -$3.29M.
What is the long-term trend for OrthoPediatrics's operating cash flow?
Over 3 years (2021 to 2024), OrthoPediatrics's operating cash flow has grown at a 27.5% compound annual growth rate (CAGR), from -$13.06M to -$27.05M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about OrthoPediatrics's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude